eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | glycogen storage disease ii |
| Comorbidity | C0026848|myopathy |
| Sentences | 4 |
| PubMedID- PMC3298100 | This last showing a vacuolar myopathy with accumulation of glycogen suggests pompe disease and leads to perform the assay acid alpha-glucosidase activity in various tissues (this can be done on skeletal muscle, fibroblasts, or blood). |
| PubMedID- 20071996 | Conclusions: the neuromuscular manifestations of glycogen storage disease type iii include myopathy and neuropathy and are more likely to occur with increasing age, even in those diagnosed with glycogen storage disease type iiib. |
| PubMedID- 25752415 | We aimed to investigate the prevalence of late-onset pompe disease among patients with a myopathy of unknown etiology, including polymyositis, or with idiopathic rise of creatine kinase (ck) levels, in a department of internal medicine. |
| PubMedID- 23668440 | Aim: dysphagia is a known complication in pompe disease (pd), a severe metabolic myopathy due to alpha-glucosidase deficiency. |
Page: 1